°µÍø½ûÇø

Accord Urges Justices To Reject 'Crush-Resistant' Oxy IP Row

By Adam Lidgett ( June 3, 2025, 5:55 PM EDT) -- Accord Healthcare Inc. says the U.S. Supreme Court should reject bankrupt OxyContin maker Purdue Pharma LP's attempt to revive its legal effort to use patent laws to block the release of a competing, "crush-resistant" generic painkiller....

°µÍø½ûÇø is on it, so you are, too.

A °µÍø½ûÇø subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A °µÍø½ûÇø subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience °µÍø½ûÇø today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm °µÍø½ûÇø's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!